Latest News

12/27/2022

Please join LIBTAYO for a live presentation on the latest data for LIBTAYO

12/15/2022

Mirati announces New Therapy Targeting KRAS G12C Mutation for Metastatic NSCLC.

11/21/2022

LIBTAYO® (cemiplimab-rwlc) is now FDA-approved

10/03/2022

The Eisai Assistance Program

Visit eisaireimbursement.com or call 1-866-61-EISAI (1-866-613-4724)

08/29/2022

Food and Drug Administration approved ibrutinib (Imbruvica, Pharmacyclics LLC) for pediatric patients

06/09/2022

Seagen Product Information Update

09/24/2007

NPPES and the NPI Registry

Many of you have noted the recent instability of NPPES and the NPI Registry. CMS has begun implementing changes that should eliminate the instability. We expect that these changes will be completed next week.

12/18/2006

DMERC Oral Anti-cancer Drugs

News & Events

Corporate Members view all sponsors